Aquestive Therapeutics Insider Trades

AQST

Track insider trading activity from Aquestive Therapeutics executives and directors. See which insiders are buying and selling AQST stock.

Trades Last 12 Months

All Insider Trades for Aquestive Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Zalewski Thomas A. Chief Legal Officer
Holding Value $403k 100,000 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$724k 175,000 shares
$4.14
$4.03
Barber Daniel President And CEO
Holding Value $2.66M 660,574 shares
Last Trade
May 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$35.4k 8,257 shares
$4.29
$4.03
Cioffi Melina Svp, Regulatory Affairs
Holding Value $1.1M 273,200 shares
Last Trade
May 15, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.95k 1,667 shares
$4.17
$4.03
Braender Lori J Corporate Secretary
Holding Value $931k 231,042 shares
Last Trade
May 07, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$574k 135,690 shares
$4.23
$4.03
Toth A Ernest Jr Chief Financial Officer
Holding Value $1.14M 283,460 shares
Last Trade
May 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$387k 92,652 shares
$4.18
$4.03
Boyd Peter E. Chief People Officer
Holding Value $1.14M 281,731 shares
Last Trade
May 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$237k 56,778 shares
$4.18
$4.03
Jung Cassie Chief Operating Officer
Holding Value $815k 202,246 shares
Last Trade
May 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$304k 72,734 shares
$4.18
$4.03
Korczynski Sherry Chief Commercial Officer
Holding Value $972k 241,117 shares
Last Trade
Mar 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$65.6k 15,741 shares
$4.17
$4.03
Davis Matthew W. Chief Development Officer
Holding Value $403k 100,000 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$429k 100,000 shares
$4.29
$4.03
Greenhawt Matthew J. Chief Medical Officer
Holding Value $302k 75,000 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$536k 125,000 shares
$4.29
$4.03
Kraus Carl N Chief Medical Officer
Holding Value $1.14M 282,475 shares
Last Trade
Oct 15, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$142k 20,272 shares
$7.00
$4.03
Taglietti Marco Director
Holding Value $169k 42,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 42,000 shares
$3.41
$4.03
Brown Gregory B Director
Holding Value $169k 42,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 42,000 shares
$3.41
$4.03
Cochran John Director
Holding Value $169k 42,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 42,000 shares
$3.41
$4.03
Holding Value $169k 42,000 shares
Last Trade
Jun 11, 2025 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 42,000 shares
$3.41
$4.03
Krop Julie Director
Holding Value $169k 42,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 42,000 shares
$3.41
$4.03
Morris Timothy E Director
Holding Value $169k 42,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 42,000 shares
$3.41
$4.03
Wargacki Stephen Chief Science Officer
Holding Value $1.38M 343,552 shares
Last Trade
Mar 10, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.6k 4,572 shares
$2.54
$4.03
Bratton Douglas K 10% owner
Holding Value $805k 199,841 shares
Last Trade
Dec 02, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$192k 40,000 shares
$4.81
$4.03
Costa Santo J Director
Holding Value $153k 38,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$95k 38,000 shares
$2.50
$4.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up